# A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer

> **NCT01784120** · PHASE2 · UNKNOWN · sponsor: **Gachon University Gil Medical Center** · enrollment: 48 (estimated)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Doxorubicin/Genexol-PM

## Key facts

- **NCT ID:** NCT01784120
- **Lead sponsor:** Gachon University Gil Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2016-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01784120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01784120, "A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01784120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*